Appian Medical Secures $580K in Seed Funding

Appian_MedicalAppian Medical, a Severna Park, MD-based mobile health company inventing and commercializing solutions for obstructive sleep apnea (OSA), secured $580k in funding.

The company, which aims to raise $1m in total, intends to use the funds to develop a diagnostic software technology licensed from The University of Queensland (UQ) in Australia.

The technology was developed by Dr. Udantha Abeyratne from the UQ School of Information Technology and Electrical Engineering and licensed to Appian Medical by Uniquest, the university’s main commercialization company.
The software uses neural network algorithms, a form of artificial intelligence, to detect the presence of OSA from the analysis of sound characteristics associated with snoring and airway collapse. In clinical studies, the technology has demonstrated the ability to distinguish OSA from snoring with a high degree of accuracy.

The company is led by Michael J. Thomas, founder and chief executive officer.

FinSMEs

12/08/2014

Join the discussion